What is CorMedix's other commercial liabilities?

CorMedix (CRMD) reported other commercial liabilities of $112.77M in Q1 2026.

How has CorMedix's other commercial liabilities changed year-over-year?

CorMedix's other commercial liabilities increased by 249.3% year-over-year, from $32.28M to $112.77M.

What is the long-term trend for CorMedix's other commercial liabilities?

Over 5 years (2020 to 2025), CorMedix's other commercial liabilities has grown at a 123.6% compound annual growth rate (CAGR), from $2.92M to $163.37M.

CorMedix CRMD Other Commercial Liabilities

Other Commercial Liabilities at other companies

Merit Medical SystemsMMSI

——

ITG

Integer HoldingsITGR

——

IAR

Integra LifeSciencesIART

——

Emergent BiosolutionsEBS

——

ICU MedicalICUI

——

TFX

TeleflexTFX

——

Other financials

Income statement

See full

Revenue$127.4M+226%

Gross profit$115.4M+207%

Operating income$63.7M+216%

Net income$38.6M+87.0%

EPS (diluted)$0.43+43.3%

Balance sheet

See full

Cash & equivalents$179.1M+170%

Total debt$4.3M+729%

Total equity$437.0M+280%

Total assets$815.6M+445%

Cash flow

See full

Operating cash flow$42.4M+115%

CapEx$729.0K+7,190%

Free cash flow$41.7M+111%

Valuation

See full

Market cap$605.65M-34.4%

P/E3.4×—

P/S1.5×-9.6×

Profitability

See full

Gross margin91.9%-3.5pp

Operating margin48.4%—

Net margin45.2%—

FCF margin48.7%+38.8pp

Returns & leverage

See full

Return on equity65.6%—

Debt / equity0×0.0×

Current ratio3×-1.2×

Where this comes from

Reported directly by CorMedix in its filing.

Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.

The official record: CorMedix’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about CorMedix's other commercial liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is CorMedix's other commercial liabilities?: CorMedix (CRMD) reported other commercial liabilities of $112.77M in Q1 2026.
How has CorMedix's other commercial liabilities changed year-over-year?: CorMedix's other commercial liabilities increased by 249.3% year-over-year, from $32.28M to $112.77M.
What is the long-term trend for CorMedix's other commercial liabilities?: Over 5 years (2020 to 2025), CorMedix's other commercial liabilities has grown at a 123.6% compound annual growth rate (CAGR), from $2.92M to $163.37M.